Retatrutide is a synthetic 39-amino-acid peptide carrying a fatty acid side chain, classified as a triple GIP, GLP-1 and glucagon receptor agonist. It is an investigational compound, not an approved drug, and is supplied as a lyophilized powder for laboratory research use.
This page collects every retatrutide-containing item in the catalog: the multi-dose lyophilized vial, the single-dose vial format, and the Mollecule GLP1-R vial and oral film strips. Available as lyophilized vials, single-dose vials and oral film strips.
Lyophilized peptide is stable at ambient temperature in transit. Store sealed vials refrigerated and protected from light; once in solution, keep refrigerated and refer to the certificate of analysis supplied with the lot.
Every lot is third-party tested at greater than 99% purity and supplied with a certificate of analysis. Research use only, not for human consumption.
Related research compounds: tirzepatide and semaglutide. The full group is in Incretin & Glucagon Receptor Ligands.